J. Hai

Association of GSTs polymorphisms with risk of gestational diabetes mellitus.

Shaoru Li, Qinggui Zhang, Di Wang, 2015, International journal of clinical and experimental pathology.

Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway.

Yongli Zhang, Sujuan Pei, Yongxiang Zhang, 2013, International immunopharmacology.

Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease.

Yongli Zhang, Kun-Sheng Li, Jie Hai, 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Association of MTHFR C 677 T and A 1298 C polymorphisms with the development of type 2 diabetic nephropathy and their interaction with environmental factors

Jie Hai, Qinggui Zhang, Di Wang, 2017 .

miRNA-33 expression and its mechanism in patients and model rats with type 2 diabetic nephropathy

Di Wang, Liwei Bai, Q. Zhai, 2018 .

Investigation on the association between inerleukin-10 -592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy.

T. Wang, Jie Hai, Jianling Wang, 2015, International journal of clinical and experimental pathology.

Inhibition of GHRH aggravated acetaminophen-induced acute mice liver injury through GH/IGF-I axis.

T. Wang, Jie Hai, Xuehui Chen, 2012, Endocrine journal.

Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development

Jie Hai, Xuehui Chen, Hua Peng, 2013, Endocrine.